Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015).
Liu, Y., Castro Bravo, K. M. & Liu, J. Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horiz. 6, 78–94 (2021).
Pattni, B. S., Chupin, V. V. & Torchilin, V. P. New developments in liposomal drug delivery. Chem. Rev. 115, 10938–10966 (2015).
Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).
Mamot, C. et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res. 65, 11631–11638 (2005).
Alavi, M. & Hamidi, M. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab. Pers. Ther. 34, 20180032 (2019).
Leserman, L. D., Machy, P. & Barbet, J. Cell-specific drug transfer from liposomes bearing monoclonal antibodies. Nature 293, 226–228 (1981).
Nellis, D. F. et al. Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification. Biotechnol. Prog. 21, 205–220 (2005).
Wu, Y. R., Sefah, K., Liu, H. P., Wang, R. W. & Tan, W. H. DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc. Natl Acad. Sci. USA 107, 5–10 (2010).
Liu, Y. N. et al. EGFR-targeted nanobody functionalized polymeric micelles loaded with mTHPC for selective photodynamic therapy. Mol. Pharm. 17, 1276–1292 (2020).
Hama, S., Sakai, M., Itakura, S., Majima, E. & Kogure, K. Rapid modification of antibodies on the surface of liposomes composed of high-affinity protein A-conjugated phospholipid for selective drug delivery. Biochem Biophys. Rep. 27, 101067 (2021).
Cho, E. J., Lee, J. W. & Ellington, A. D. Applications of aptamers as sensors. Annu. Rev. Anal. Chem. 2, 241–264 (2009).
Ma et al. Nucleic acid aptamers in cancer research, diagnosis and therapy. Chem. Soc. Rev. 44, 1240–1256 (2015).
Li, L. et al. Nucleic acid aptamers for molecular diagnostics and therapeutics: advances and perspectives. Angew. Chem. Int. Ed. Engl. 60, 2221–2231 (2021).
Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 82, 775–797 (2013).
Chen, X., Zaro, J. L. & Shen, W. C. Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357–1369 (2013).
Finger, C., Escher, C. & Schneider, D. The single transmembrane domains of human receptor tyrosine kinases encode self-interactions. Sci. Signal 2, ra56 (2009).
Lāce, I., Cotroneo, E. R., Hesselbarth, N. & Simeth, N. A. Artificial peptides to induce membrane denaturation and disruption and modulate membrane composition and fusion. J. Pept. Sci. 29, e3466 (2023).
Rahman, M. M., Ueda, M., Hirose, T. & Ito, Y. Spontaneous formation of gating lipid domain in uniform-size peptide vesicles for controlled release. J. Am. Chem. Soc. 140, 17956–17961 (2018).
Chen, Z., Moon, J. J. & Cheng, W. Quantitation and stability of protein conjugation on liposomes for controlled density of surface epitopes. Bioconjug. Chem. 29, 1251–1260 (2018).
Oliveira, S. et al. Downregulation of EGFR by a novel multivalent nanobody-liposome platform. J. Control. Release 145, 165–175 (2010).
van der Meel, R. et al. Tumor-targeted nanobullets: anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. J. Control. Release 159, 281–289 (2012).
Li, N. et al. Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury. Drug Deliv. 24, 1770–1781 (2017).
Khaleghi, S., Rahbarizadeh, F., Ahmadvand, D. & Hosseini, H. R. M. Anti-HER2 VHH targeted magnetoliposome for intelligent magnetic resonance imaging of breast cancer cells. Cell. Mol. Bioeng. 10, 263–272 (2017).
Woll, S. et al. Sortagging of liposomes with a murine CD11b-specific VHH increases in vitro and in vivo targeting specificity of myeloid cells. Eur. J. Pharm. Biopharm. 134, 190–198 (2019).
Mesquita, B. S. et al. The impact of nanobody density on the targeting efficiency of PEGylated liposomes. Int. J. Mol. Sci. 23, 14974 (2022).
Nishimura, T., Hirose, S., Sasaki, Y. & Akiyoshi, K. Substrate-sorting nanoreactors based on permeable peptide polymer vesicles and hybrid liposomes with synthetic macromolecular channels. J. Am. Chem. Soc. 142, 154–161 (2020).
Golfetto, O., Hinde, E. & Gratton, E. Laurdan fluorescence lifetime discriminates cholesterol content from changes in fluidity in living cell membranes. Biophys. J. 104, 1238–1247 (2013).
Marsh, D. Thermodynamics of phospholipid self-assembly. Biophys. J. 102, 1079–1087 (2012).
Hessa, T. et al. Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 450, 1026–1030 (2007).
Wan, Y. et al. Velocity effect on aptamer-based circulating tumor cell isolation in microfluidic devices. J. Phys. Chem. B 115, 13891–13896 (2011).
Grillo, I., Morfin, I. & Prevost, S. Structural characterization of pluronic micelles swollen with perfume molecules. Langmuir 34, 13395–13408 (2018).
Andersen, T. et al. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy. Mar. Drugs 13, 222–236 (2015).
Takikawa, M., Fujisawa, M., Yoshino, K. & Takeoka, S. Intracellular distribution of lipids and encapsulated model drugs from cationic liposomes with different uptake pathways. Int J. Nanomed. 15, 8401–8409 (2020).
Lin, W. S. & Malmstadt, N. Liposome production and concurrent loading of drug simulants by microfluidic hydrodynamic focusing. Eur. Biophys. J. 48, 549–558 (2019).
Haque, M. E., McIntosh, T. J. & Lentz, B. R. Influence of lipid composition on physical properties and PEG-mediated fusion of curved and uncurved model membrane vesicles: “Nature’s own” fusogenic lipid bilayer. Biochemistry 40, 4340–4348 (2001).
Rahman, M. M., Abosheasha, M. A., Ito, Y. & Ueda, M. DNA-induced fusion between lipid domains of peptide–lipid hybrid vesicles. Chem. Commun. 58, 11799–11802 (2022).
Dominguez, L., Foster, L., Straub, J. E. & Thirumalai, D. Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein. Proc. Natl Acad. Sci. USA 113, E5281–E5287 (2016).
Wang, B. H. et al. Sequential intercellular delivery nanosystem for enhancing ROS-Induced antitumor therapy. Nano Lett. 19, 3505–3518 (2019).
Tarafdar, P. K., Chakraborty, H., Dennison, S. M. & Lentz, B. R. Phosphatidylserine inhibits and calcium promotes model membrane fusion. Biophys. J. 103, 1880–1889 (2012).
Lygina, A. S., Meyenberg, K., Jahn, R. & Diederichsen, U. Transmembrane domain peptide/peptide nucleic acid hybrid as a model of a SNARE protein in vesicle fusion. Angew. Chem. Int Ed. 50, 8597–8601 (2011).
Risselada, H. J., Kutzner, C. & Grubmuller, H. Caught in the act: visualization of SNARE-mediated fusion events in molecular detail. ChemBioChem 12, 1049–2011 (2011).
Kaiser, H. J. et al. Lateral sorting in model membranes by cholesterol-mediated hydrophobic matching. Proc. Natl Acad. Sci. USA 108, 16628–16633 (2011).
Kozlowska, D. et al. Gadolinium-loaded polychelating amphiphilic polymer as an enhanced MRI contrast agent for human multiple myeloma and non Hodgkin’s lymphoma (human Burkitt’s lymphoma). RSC Adv. 4, 18007–18016 (2014).
Ingolfsson, H. I. et al. Lipid organization of the plasma membrane. J. Am. Chem. Soc. 136, 14554–14559 (2014).
Scheve, C. S., Gonzales, P. A., Momin, N. & Stachowiak, J. C. Steric pressure between membrane-bound proteins opposes lipid phase separation. J. Am. Chem. Soc. 135, 1185–1188 (2013).
Schafer, L. V. et al. Lipid packing drives the segregation of transmembrane helices into disordered lipid domains in model membranes. Proc. Natl Acad. Sci. USA 108, 1343–1348 (2011).
Lomize, A. L., Lomize, M. A., Krolicki, S. R. & Pogozheva, I. D. Membranome: a database for proteome-wide analysis of single-pass membrane proteins. Nucleic Acids Res. 45, D250–D255 (2017).
Pardon, E. et al. A general protocol for the generation of nanobodies for structural biology. Nat. Protoc. 9, 674–693 (2014).
Jovcevska, I. et al. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. PLoS ONE 9, e113688 (2014).
Hmila, I. et al. A bispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 24, 3479–3489 (2010).
Farajpour, Z., Rahbarizadeh, F., Kazemi, B. & Ahmadvand, D. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment. Biochem. Biophys. Res. Commun. 446, 132–136 (2014).
Roovers, R. C. et al. A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth. Int. J. Cancer 129, 2013–2024 (2011).
Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015).
Nguyen, H., Maier, J., Huang, H., Perrone, V. & Simmerling, C. Folding simulations for proteins with diverse topologies are accessible in days with a physics-based force field and implicit solvent. J. Am. Chem. Soc. 136, 13959–13962 (2014).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
DeLano W. L. PyMOL molecular viewer: updates and refinements. Abstr. Pap. Am. Chem. S 238, (2009).
Genheden, S. & Ryde, U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449–461 (2015).
Valdes-Tresanco, M. S., Valdes-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281–6291 (2021).
Et-Thakafy, O. et al. Mechanical properties of membranes composed of gel-phase or fluid-phase phospholipids probed on liposomes by atomic force spectroscopy. Langmuir 33, 5117–5126 (2017).
Dokukin, M. E. & Sokolov, I. Quantitative mapping of the elastic modulus of soft materials with HarmoniX and PeakForce QNM AFM modes. Langmuir 28, 16060–16071 (2012).
Custodio, T. F. et al. Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2. Nat. Commun. 11, 5588 (2020).
Callister, W. D. & Rethwisch, D. G. Materials Science and Engineering: An Introduction Vol. 7 (Wiley, 2020).
McQuarrie, D. A., Jachimowski, C. & Russell, M. Kinetics of small systems. II. J. Chem. Phys. 40, 2914–2921 (1964).
Decuzzi, P. & Ferrari, M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27, 5307–5314 (2006).
Piper, J. W., Swerlick, R. A. & Zhu, C. Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation. Biophys. J. 74, 492–513 (1998).
Goldman, A. J., Cox, R. G. & Brenner, H. Slow viscous motion of a sphere parallel to a plane wall 0.2. Couette flow. Chem. Eng. Sci. 22, 637–651 (1967).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41565-024-01620-6
